IMA Wealth Inc. Cuts Stock Holdings in Abbott Laboratories (NYSE:ABT)

IMA Wealth Inc. trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,152 shares of the healthcare product maker’s stock after selling 250 shares during the […]

Related Keywords

Canada ,Raymond James ,Andreaf Wainer ,Johna Jr ,Royal Bank ,Citigroup ,Abbott Laboratories ,Wealth Inc ,Securities Exchange Commission ,Exchange Commission ,Stuart Chaussee Associates Inc ,Gilliland Jeter Wealth Management ,Ima Wealth Inc ,Alliance Wealth Advisors ,Headlands Technologies ,Barclays ,Free Report ,Wealth Advisors ,Jeter Wealth Management ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Visit Holdingschannel ,Abbott Laboratories Daily ,Nyse Abt ,Abt ,Medical ,00282410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,